Temperature Controlled Packaging Market Segmentation
Temperature Controlled Packaging For Pharmaceutical Product Outlook
Temperature Controlled Packaging For Pharmaceutical Type Outlook
Temperature Controlled Packaging For Pharmaceutical Temperature Range Outlook
Temperature Controlled Packaging For Pharmaceutical End-Use Industry Outlook
Temperature Controlled Packaging For Pharmaceutical Regional Outlook (USD Million, 2018-2030)
Research Methodology on Temperature-Controlled Packaging for Pharmaceutical Market
Introduction
The aim of this research report is to provide a comprehensive research analysis of the global temperature-controlled packaging for the pharmaceuticals market. Temperature-controlled packaging is primarily used within the pharmaceutical industry to keep goods at a specific temperature range, protecting them from damage and contamination. Over the past decades, the implementation of stringent regulations and standards, growing demand for biologics, and technological advancements have led to breakthroughs in temperature-controlled packaging for pharmaceuticals. Market analysis is conducted for temperature-controlled packaging for pharmaceuticals in this research study focusing on qualitative and quantitative aspects. Some of the main drivers and challenges of this market and future opportunities are also discussed in the published research report.
Research Methodology
The primary methodology to create the research report is an exhaustive questionnaire consisting of both qualitative and quantitative questions. In terms of qualitative analysis, the interviewers assessed the respondents' behaviour, opinion, attitude and other related factors. In quantitative methodology, a well-structured questionnaire with a structured Likert scale and a key question to ascertain the knowledge and expertise of the respondents is generated. The questionnaire is sent out to pharmaceutical experts, vendors and end users.
Sampling
A purposive sampling technique is employed for the research survey. This sampling technique is mainly used when there is an intention to study a particular population segment. MRFR's sample was drawn from participants located in different countries. There was a range of participants from each country involved in temperature-controlled pharmaceutical packaging. In order to obtain an accurate representation of the population, a maximum variation sampling technique was used. The sampling frame in this study includes a range of temperature-controlled packaging experts from the pharmaceutical industry based on their experience and expertise in the field.
Data Collection
The major sources of information used in the research are a review of secondary literature and online surveys. Secondary data collection includes reviewing published work on temperature-controlled packaging for pharmaceuticals, newspaper articles and reviews. To conduct the online survey, the questionnaire is designed, the survey is conducted using survey software, and collected responses are analyzed. The data collected through predominantly primary sources are validated in discussions with industry participants and experts.
Data Analysis
For analysis of the data collected, the descriptive statistical analysis method is used. The descriptive analysis includes the calculation of summary statistics such as arithmetic mean, frequency, percentages, standard deviation etc. A descriptive analysis is conducted to determine the relevancy of the data collected. Also, inferential statistical analysis is used to examine the variables' association. The inferential analysis includes a t-test, Chi-square test, Correlation analysis etc. Further, multivariate analysis is used to identify latent relationships among the data. Multiple regression analysis is used to predict the expected value of the outcomes.
Qualitative Analysis
The secondary sources used during the research include journals, press releases, reports, company websites, and others. Furthermore, the primary sources used were questionnaires. A questionnaire was developed, and an online survey was conducted among the experts associated with temperature-controlled pharmaceutical packaging. The questionnaire included open-ended questions, dichotomous questions and multiple-choice questions. After collecting and analyzing the responses, the survey results are used for further analysis.
Conclusion
Overall, this methodology provides the researcher with a comprehensive understanding of temperature-controlled packaging for the pharmaceuticals market. Statistical analysis is used to perform quantitative analysis, while qualitative analysis is used to obtain qualitative insights into the market. After exhaustive research, projections for the future of temperature-controlled packaging for the pharmaceuticals market are made for the forecast period 2023 to 2030.
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
1.1 MARKET ATTRACTIVENESS ANALYSIS
1.1.1 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET BY PRODUCT
1.1.2 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE
1.1.3 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE
1.1.4 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY
1.1.5 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE
1.1.6 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE
1.1.7 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 MARKET STRUCTURE
3 RESEARCH METHODOLOGY
3.1 RESEARCH PROCESS
3.2 PRIMARY RESEARCH
3.3 SECONDARY RESEARCH
3.4 MARKET SIZE ESTIMATION
3.5 TOP-DOWN AND BOTTOM-UP APPROACH
3.6 FORECAST MODEL
3.7 LIST OF ASSUMPTIONS
4 MARKET DYNAMICS
4.1 INTRODUCTION
4.2 DRIVERS
4.2.1 GROWTH IN THE PHARMACEUTICAL INDUSTRY SUPPLEMENTING SALES TO THE SIGNIFICANT EXTENT
4.2.2 ADOPTION OF SMARTER COLD CHAIN TECHNOLOGY
4.2.3 DRIVER IMPACT ANALYSIS
4.3 RESTRAINTS
4.3.1 RISE IN RAW MATERIAL COSTS
4.3.2 RESTRAINT IMPACT ANALYSIS
4.4 OPPORTUNITY
4.4.1 VARIOUS GOVERNMENT INITIATIVES ARE CARRIED OUT BY VARIOUS COUNTRIES TO BOOST THE PHARMACEUTICAL INDUSTRY
4.4.2 INCREASE IN R & D INVESTMENT IN THE PHARMACEUTICAL INDUSTRY OFFERING REVENUE-GENERATING OPPORTUNITIES
4.4.3 SUSTAINABILITY AND PHARMACEUTICAL TEMPERATURE CONTROL PACKAGING
4.5 IMPACT OF COVID-19 ANALYSIS
4.5.1 ECONOMIC IMPACT
4.5.1.1 IMPACT ON THE PACKAGING INDUSTRY
4.5.2 IMPACT ON PRODUCTION
4.5.3 IMPACT ON TEMPERATURE-CONTROLLED PACKAGING FOR THE PHARMACEUTICAL INDUSTRY
4.5.3.1 IMPACT ON SUPPLY CHAIN
4.5.3.2 IMPACT ON RAW MATERIALS
4.5.3.3 CASH FLOW CONSTRAINTS
4.5.4 IMPACT ON WORLD TRADE
5 MARKET FACTOR ANALYSIS
5.1 PORTER’S FIVE FORCES MODEL
5.1.1 THREAT OF NEW ENTRANTS
5.1.2 BARGAINING POWER OF SUPPLIERS
5.1.3 THREAT OF SUBSTITUTES
5.1.4 BARGAINING POWER OF BUYERS
5.1.5 INTENSITY OF RIVALRY
5.2 SUPPLY CHAIN ANALYSIS
5.2.1 DESIGN AND DEVELOPMENT
5.2.2 RAW MATERIAL SUPPLY
5.2.3 MANUFACTURER
5.2.4 DISTRIBUTION
5.2.5 END-USERS
6 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT
6.1 OVERVIEW
6.2 SHIPPERS
6.3 CONTAINERS
7 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE
7.1 OVERVIEW
7.2 ACTIVE SYSTEM
7.3 PASSIVE SYSTEM
8 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE
8.1 OVERVIEW
8.2 -20°C AND BELOW
8.3 -20°C TO -10°C
8.4 - 10°C TO 10°C
8.5 10°C TO 20°C
8.6 ABOVE 20°C
9 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY
9.1 OVERVIEW
9.2 UP TO 10 L
9.3 10 L - 20 L
9.4 20 L - 40 L
9.5 40 L - 150 L
9.6 ABOVE 150 L
10 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE
10.1 OVERVIEW
10.2 SINGLE USE
10.3 REUSABLE
11 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE
11.1 OVERVIEW
11.2 TEMPERATURE SENSITIVE PHARMACEUTICAL DRUGS
11.3 VACCINE
11.4 REGENERATIVE MEDICINE
12 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY
12.1 OVERVIEW
12.2 PHARMACEUTICALS
12.3 CLINICAL TRAILS
13 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY REGION
13.1 OVERVIEW
13.1.1 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY REGION, 2018–2030
13.2 NORTH AMERICA
13.2.1 NORTH AMERICA: TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY COUNTRY, 2018–2030
13.2.2 US
13.2.3 CANADA
13.3 EUROPE
13.3.1 EUROPE: TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY COUNTRY, 2018–2030
13.3.2 GERMANY
13.3.3 FRANCE
13.3.4 UK
13.3.5 ITALY
13.3.6 SPAIN
13.3.7 REST OF EUROPE
13.4 ASIA PACIFIC
13.4.1 ASIA PACIFIC: TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY COUNTRY, 2018–2030
13.4.2 CHINA
13.4.3 JAPAN
13.4.4 INDIA
13.4.5 SOUTH KOREA
13.4.6 TAIWAN
13.4.7 PHILIPPINES
13.4.8 INDONESIA
13.4.9 THAILAND
13.4.10 MALAYSIA
13.4.11 SINGAPORE
13.4.12 HONG KONG
13.4.13 AUSTRALIA
13.4.14 REST OF APAC
13.5 REST OF WORLD
13.5.1 REST OF WORLD: TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY COUNTRY, 2018–2030
13.5.2 MIDDLE EAST & AFRICA
13.5.3 SOUTH AMERICA
14 COMPETITIVE LANDSCAPE
14.1 OVERVIEW
14.2 COMPETITIVE BENCHMARKING
14.3 MARKET SHARE ANALYSIS
14.4 KEY DEVELOPMENTS IN THE GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR THE PHARMACEUTICAL MARKET
14.4.1 ACQUISITION
14.4.2 EXPANSION
14.4.3 PARTNERSHIP/AGREEMANT
14.4.4 PRODUCT LAUNCH/PRODUCT APPROVAL
14.4.5 PRODUCT DEVELOPMENT
14.4.6 COLLABORATION
15 COMPANY PROFILES
15.1 COLD CHAIN TECHNOLOGIES, LLC
15.1.1 COMPANY OVERVIEW
15.1.2 FINANCIAL OVERVIEW
15.1.3 PRODUCTS OFFERED
15.1.4 KEY DEVELOPMENTS
15.1.5 SWOT ANALYSIS
15.1.6 KEY STRATEGIES
15.2 EMBALL’ISO
15.2.1 COMPANY OVERVIEW
15.2.2 FINANCIAL OVERVIEW
15.2.3 PRODUCTS OFFERED
15.2.4 KEY DEVELOPMENTS
15.2.5 SWOT ANALYSIS
15.2.6 KEY STRATEGIES
15.3 INMARK, LLC
15.3.1 COMPANY OVERVIEW
15.3.2 FINANCIAL OVERVIEW
15.3.3 PRODUCTS OFFERED
15.3.4 KEY DEVELOPMENTS
15.3.5 SWOT ANALYSIS
15.3.6 KEY STRATEGIES
15.4 SONOCO THERMOSAFE
15.4.1 COMPANY OVERVIEW
15.4.2 FINANCIAL OVERVIEW
15.4.3 PRODUCTS OFFERED
15.4.4 KEY DEVELOPMENTS
15.4.5 SWOT ANALYSIS
15.4.6 KEY STRATEGIES
15.5 VA-Q-TEC AG
15.5.1 COMPANY OVERVIEW
15.5.2 FINANCIAL OVERVIEW
15.5.3 PRODUCTS OFFERED
15.5.4 KEY DEVELOPMENTS
15.5.5 SWOT ANALYSIS
15.5.6 KEY STRATEGIES
15.6 DEUTSCHE BAHN AG
15.6.1 COMPANY OVERVIEW
15.6.2 FINANCIAL OVERVIEW
15.6.3 PRODUCTS OFFERED
15.6.4 KEY DEVELOPMENTS
15.6.5 SWOT ANALYSIS
15.6.6 KEY STRATEGIES
15.7 DHL INTERNATIONAL GMBH
15.7.1 COMPANY OVERVIEW
15.7.2 FINANCIAL OVERVIEW
15.7.3 PRODUCTS OFFERED
15.7.4 KEY DEVELOPMENTS
15.7.5 SWOT ANALYSIS
15.7.6 KEY STRATEGIES
15.8 KUEHNE + NAGEL INC.
15.8.1 COMPANY OVERVIEW
15.8.2 FINANCIAL OVERVIEW
15.8.3 PRODUCTS OFFERED
15.8.4 KEY DEVELOPMENTS
15.8.5 SWOT ANALYSIS
15.8.6 KEY STRATEGIES
15.9 UNITED PARCEL SERVICE OF AMERICA, INC.
15.9.1 COMPANY OVERVIEW
15.9.2 FINANCIAL OVERVIEW
15.9.3 PRODUCTS OFFERED
15.9.4 KEY DEVELOPMENTS
15.9.5 SWOT ANALYSIS
15.9.6 KEY STRATEGIES
15.10 KANEKA CORPORATION
15.10.1 COMPANY OVERVIEW
15.10.2 FINANCIAL OVERVIEW
15.10.3 PRODUCTS OFFERED
15.10.4 KEY DEVELOPMENTS
15.10.5 SWOT ANALYSIS
15.10.6 KEY STRATEGIES
15.11 CSAFE GLOBAL
15.11.1 COMPANY OVERVIEW
15.11.2 FINANCIAL OVERVIEW
15.11.3 PRODUCTS OFFERED
15.11.4 KEY DEVELOPMENTS
15.11.5 SWOT ANALYSIS
15.11.6 KEY STRATEGIES
LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS
TABLE 2 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT 2018–2030 (USD MILLION)
TABLE 3 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)
TABLE 4 TEMPERATURE RANGE: GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)
TABLE 5 TEMPERATURE RANGE: GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)
TABLE 6 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)
TABLE 7 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 8 REGENERATIVE MEDICINE: GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 9 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)
TABLE 10 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY REGION, 2018–2030 (USD MILLION)
TABLE 11 NORTH AMERICA: TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY COUNTRY, 2018–2030 (USD MILLION)
TABLE 12 NORTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)
TABLE 13 NORTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)
TABLE 14 NORTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)
TABLE 15 NORTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)
TABLE 16 NORTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)
TABLE 17 NORTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 18 REGENERATIVE MEDICINE: NORTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 19 NORTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)
TABLE 20 USA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)
TABLE 21 USA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)
TABLE 22 USA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)
TABLE 23 USA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)
TABLE 24 USA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)
TABLE 25 USA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 26 REGENERATIVE MEDICINE: USA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 27 USA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)
TABLE 28 CANADATEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)
TABLE 29 CANADA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)
TABLE 30 CANADA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)
TABLE 31 CANADA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)
TABLE 32 CANADA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)
TABLE 33 CANADA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 34 REGENERATIVE MEDICINE: USA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 35 CANADA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)
TABLE 36 EUROPE: TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY COUNTRY, 2018–2030 (USD MILLION)
TABLE 37 EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)
TABLE 38 EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)
TABLE 39 EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)
TABLE 40 EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)
TABLE 41 EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)
TABLE 42 EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 43 REGENERATIVE MEDICINE: EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 44 EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)
TABLE 45 GERMANY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)
TABLE 46 GERMANY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)
TABLE 47 GERMANY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)
TABLE 48 GERMANY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)
TABLE 49 GERMANY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)
TABLE 50 GERMANY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 51 REGENERATIVE MEDICINE: GERMANY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 52 GERMANY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)
TABLE 53 FRANCE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)
TABLE 54 FRANCE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)
TABLE 55 FRANCE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)
TABLE 56 FRANCE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)
TABLE 57 FRANCE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)
TABLE 58 FRANCE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 59 REGENERATIVE MEDICINE: FRANCE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 60 FRANCE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)
TABLE 61 UK TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)
TABLE 62 UK TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)
TABLE 63 UK TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)
TABLE 64 UK TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)
TABLE 65 UK TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)
TABLE 66 UK TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 67 REGENERATIVE MEDICINE: UK TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 68 UK TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)
TABLE 69 ITALY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)
TABLE 70 ITALY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)
TABLE 71 ITALY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)
TABLE 72 ITALY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)
TABLE 73 ITALY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)
TABLE 74 ITALY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 75 REGENERATIVE MEDICINE: ITALY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 76 ITALY TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)
TABLE 77 SPAIN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)
TABLE 78 SPAIN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)
TABLE 79 SPAIN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)
TABLE 80 SPAIN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)
TABLE 81 SPAIN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)
TABLE 82 SPAIN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 83 REGENERATIVE MEDICINE: SPAIN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 84 SPAIN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)
TABLE 85 REST OF EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)
TABLE 86 REST OF EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)
TABLE 87 REST OF EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)
TABLE 88 REST OF EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)
TABLE 89 REST OF EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)
TABLE 90 REST OF EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 91 REGENERATIVE MEDICINE: REST OF EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 92 REST OF EUROPE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)
TABLE 93 ASIA PACIFIC: TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY COUNTRY, 2018–2030 (USD MILLION)
TABLE 94 ASIA PACIFIC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)
TABLE 95 ASIA PACIFIC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)
TABLE 96 ASIA PACIFIC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)
TABLE 97 ASIA PACIFIC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)
TABLE 98 ASIA PACIFIC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)
TABLE 99 ASIA PACIFIC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 100 REGENERATIVE MEDICINE: ASIA PACIFIC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 101 ASIA PACIFIC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)
TABLE 102 CHINA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)
TABLE 103 CHINA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)
TABLE 104 CHINA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)
TABLE 105 CHINA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)
TABLE 106 CHINA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)
TABLE 107 CHINA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 108 REGENERATIVE MEDICINE: CHINA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 109 CHINA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)
TABLE 110 JAPAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)
TABLE 111 JAPAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)
TABLE 112 JAPAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)
TABLE 113 JAPAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)
TABLE 114 JAPAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)
TABLE 115 JAPAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 116 REGENERATIVE MEDICINE: JAPAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 117 JAPAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)
TABLE 118 INDIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)
TABLE 119 INDIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)
TABLE 120 INDIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)
TABLE 121 INDIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)
TABLE 122 INDIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)
TABLE 123 INDIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 124 REGENERATIVE MEDICINE: INDIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 125 INDIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)
TABLE 126 SOUTH KOREA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)
TABLE 127 SOUTH KOREA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)
TABLE 128 SOUTH KOREA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)
TABLE 129 SOUTH KOREA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)
TABLE 130 SOUTH KOREA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)
TABLE 131 SOUTH KOREA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 132 REGENERATIVE MEDICINE: SOUTH KOREA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 133 SOUTH KOREA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)
TABLE 134 TAIWAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)
TABLE 135 TAIWAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)
TABLE 136 TAIWAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)
TABLE 137 TAIWAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)
TABLE 138 TAIWAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)
TABLE 139 TAIWAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 140 REGENERATIVE MEDICINE: TAIWAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 141 TAIWAN TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)
TABLE 142 PHILIPPINES TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)
TABLE 143 PHILIPPINES TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)
TABLE 144 PHILIPPINES TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)
TABLE 145 PHILIPPINES TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)
TABLE 146 PHILIPPINES TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)
TABLE 147 PHILIPPINES TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 148 REGENERATIVE MEDICINE: PHILIPPINES TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 149 PHILIPPINES TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)
TABLE 150 INDONESIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)
TABLE 151 INDONESIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)
TABLE 152 INDONESIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)
TABLE 153 INDONESIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)
TABLE 154 INDONESIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)
TABLE 155 INDONESIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 156 REGENERATIVE MEDICINE: INDONESIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 157 INDONESIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)
TABLE 158 THAILAND TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)
TABLE 159 THAILAND TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)
TABLE 160 THAILAND TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)
TABLE 161 THAILAND TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)
TABLE 162 THAILAND TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)
TABLE 163 THAILAND TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 164 REGENERATIVE MEDICINE: THAILAND TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 165 THAILAND TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)
TABLE 166 MALAYSIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)
TABLE 167 MALAYSIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)
TABLE 168 MALAYSIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)
TABLE 169 MALAYSIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)
TABLE 170 MALAYSIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)
TABLE 171 MALAYSIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 172 REGENERATIVE MEDICINE: MALAYSIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 173 MALAYSIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)
TABLE 174 SINGAPORE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)
TABLE 175 SINGAPORE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)
TABLE 176 SINGAPORE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)
TABLE 177 SINGAPORE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)
TABLE 178 SINGAPORE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)
TABLE 179 SINGAPORE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 180 REGENERATIVE MEDICINE: SINGAPORE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 181 SINGAPORE TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)
TABLE 182 HONG KONG TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)
TABLE 183 HONG KONG TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)
TABLE 184 HONG KONG TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)
TABLE 185 HONG KONG TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)
TABLE 186 HONG KONG TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)
TABLE 187 HONG KONG TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 188 REGENERATIVE MEDICINE: HONG KONG TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 189 HONG KONG TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)
TABLE 190 AUSTRALIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)
TABLE 191 AUSTRALIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)
TABLE 192 AUSTRALIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)
TABLE 193 AUSTRALIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)
TABLE 194 AUSTRALIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)
TABLE 195 AUSTRALIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 196 REGENERATIVE MEDICINE: AUSTRALIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 197 AUSTRALIA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)
TABLE 198 REST OF APAC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)
TABLE 199 REST OF APAC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)
TABLE 200 REST OF APAC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)
TABLE 201 REST OF APAC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)
TABLE 202 REST OF APAC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)
TABLE 203 REST OF APAC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 204 REGENERATIVE MEDICINE: REST OF APAC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 205 REST OF APAC TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)
TABLE 206 REST OF WORLD: TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY COUNTRY, 2018–2030 (USD MILLION)
TABLE 207 REST OF WORLD TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)
TABLE 208 REST OF WORLD TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)
TABLE 209 REST OF WORLD TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)
TABLE 210 REST OF WORLD TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)
TABLE 211 REST OF WORLD TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)
TABLE 212 REST OF WORLD TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 213 REGENERATIVE MEDICINE: REST OF WORLD TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 214 REST OF WORLD TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)
TABLE 215 MIDDLE EAST & AFRICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)
TABLE 216 MIDDLE EAST & AFRICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)
TABLE 217 MIDDLE EAST & AFRICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)
TABLE 218 MIDDLE EAST & AFRICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)
TABLE 219 MIDDLE EAST & AFRICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)
TABLE 220 MIDDLE EAST & AFRICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 221 REGENERATIVE MEDICINE: MIDDLE EAST & AFRICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 222 MIDDLE EAST & AFRICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)
TABLE 223 SOUTH AMERICATEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)
TABLE 224 SOUTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE 2018–2030 (USD MILLION)
TABLE 225 SOUTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE 2018–2030 (USD MILLION)
TABLE 226 SOUTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY 2018–2030 (USD MILLION)
TABLE 227 SOUTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE 2018–2030 (USD MILLION)
TABLE 228 SOUTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 229 REGENERATIVE MEDICINE: SOUTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE 2018–2030 (USD MILLION)
TABLE 230 SOUTH AMERICA TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY 2018–2030 (USD MILLION)
TABLE 231 ACQUISITION
TABLE 232 EXPANSION
TABLE 233 PARTNERSHIP/AGREEMENT
TABLE 234 PRODUCT LAUNCH/PRODUCT APPROVAL
TABLE 235 PRODUCT DEVELOPMENT
TABLE 236 COLLABORATION
TABLE 237 COLD CHAIN TECHNOLOGIES, LLC: PRODUCTS OFFERED
TABLE 238 COLD CHAIN TECHNOLOGIES, LLC: KEY DEVELOPMENTS
TABLE 239 EMBALL’ISO: PRODUCTS OFFERED
TABLE 240 INMARK INC: PRODUCTS OFFERED
TABLE 241 SONOCO THERMOSAFE: PRODUCTS OFFERED
TABLE 242 SONOCO THERMOSAFE: KEY DEVELOPMENTS
TABLE 243 VA-Q-TEC AG: PRODUCTS OFFERED
TABLE 244 VA-Q-TEC AG: KEY DEVELOPMENTS
TABLE 245 DEUTSCHE BAHN AG: PRODUCTS OFFERED
TABLE 246 DHL INTERNATIONAL GMBH: PRODUCTS OFFERED
TABLE 247 DHL INTERNATIONAL GMBH: KEY DEVELOPMENTS
TABLE 248 KUEHNE + NAGEL INC.: PRODUCTS OFFERED
TABLE 249 KUEHNE + NAGEL INC.: KEY DEVELOPMENTS
TABLE 250 UNITED PARCEL SERVICE OF AMERICA, INC.: PRODUCTS OFFERED
TABLE 251 UNITED PARCEL SERVICE OF AMERICA, INC.: KEY DEVELOPMENTS
TABLE 252 KANEKA CORPORATION: PRODUCTS OFFERED
TABLE 253 KANEKA CORPORATION: KEY DEVELOPMENTS
TABLE 254 CSAFE GLOBAL: PRODUCTS OFFERED
TABLE 255 CSAFE GLOBAL: KEY DEVELOPMENTS
LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS
FIGURE 2 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET ANALYSIS, BY PRODUCT
FIGURE 3 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET ANALYSIS, BY TYPE
FIGURE 4 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET ANALYSIS, BY TEMPERATURE RANGE
FIGURE 5 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET ANALYSIS, BY PAYLOAD CAPACITY
FIGURE 6 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET ANALYSIS, BY USE
FIGURE 7 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET ANALYSIS, BY MEDICINE TYPE
FIGURE 8 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET ANALYSIS BY END USE INDUSTRY
FIGURE 9 GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET: MARKET STRUCTURE
FIGURE 10 RESEARCH PROCESS OF MRFR
FIGURE 11 MARKET DYNAMICS: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET
FIGURE 12 DRIVER IMPACT ANALYSIS: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR THE PHARMACEUTICAL MARKET
FIGURE 13 RESTRAINT IMPACT ANALYSIS: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR THE PHARMACEUTICAL MARKET
FIGURE 14 PORTER’S FIVE FORCES ANALYSIS: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET
FIGURE 15 SUPPLY CHAIN ANALYSIS: GLOBAL TEMPERATURE-CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET
FIGURE 16 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2021 (% SHARE)
FIGURE 17 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PRODUCT, 2018–2030 (USD MILLION)
FIGURE 18 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE, 2021 (% SHARE)
FIGURE 19 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TYPE, 2018–2030 (USD MILLION)
FIGURE 20 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE, 2021 (% SHARE)
FIGURE 21 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY TEMPERATURE RANGE, 2018–2030 (USD MILLION)
FIGURE 22 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY, 2021 (% SHARE)
FIGURE 23 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY PAYLOAD CAPACITY, 2018–2030 (USD MILLION)
FIGURE 24 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE, 2021 (% SHARE)
FIGURE 25 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY USE, 2018–2030 (USD MILLION)
FIGURE 26 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE, 2021 (% SHARE)
FIGURE 27 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY MEDICINE TYPE, 2018–2030 (USD MILLION)
FIGURE 28 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY, 2021 (% SHARE)
FIGURE 29 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY END USE INDUSTRY, 2018–2030 (USD MILLION)
FIGURE 30 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY REGION, 2021 (% SHARE)
FIGURE 31 GLOBAL TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET, BY REGION, 2018-2027
FIGURE 32 NORTH AMERICA: TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET SHARE, BY COUNTRY, 2021 (% SHARE)
FIGURE 33 EUROPE: TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET SHARE, BY COUNTRY, 2021 (% SHARE)
FIGURE 34 ASIA PACIFIC: TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET SHARE, BY COUNTRY, 2021 (% SHARE)
FIGURE 35 REST OF WORLD: TEMPERATURE CONTROLLED PACKAGING FOR PHARMACEUTICAL MARKET SHARE, BY COUNTRY, 2021 (% SHARE)
FIGURE 36 BENCHMARKING OF MAJOR COMPETITORS
FIGURE 37 MARKET SHARE ANALYSIS, 2021
FIGURE 38 COLD CHAIN TECHNOLOGIES, LLC: SWOT ANALYSIS
FIGURE 39 EMBALL’ISO: SWOT ANALYSIS
FIGURE 40 INMARK, LLC: SWOT ANALYSIS
FIGURE 41 SONOCO THERMOSAFE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 42 SONOCO THERMOSAFE: SWOT ANALYSIS
FIGURE 43 VA-Q-TEC AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 44 VA-Q-TEC AG: SWOT ANALYSIS
FIGURE 45 DEUTSCHE BAHN AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 46 DEUTSCHE BAHN AG: SWOT ANALYSIS
FIGURE 47 DHL INTERNATIONAL GMBH: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 48 DHL INTERNATIONAL GMBH: SWOT ANALYSIS
FIGURE 49 KUEHNE + NAGEL INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 50 KUEHNE + NAGEL INC.: SWOT ANALYSIS
FIGURE 51 UNITED PARCEL SERVICE OF AMERICA, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 52 UNITED PARCEL SERVICE OF AMERICA, INC.: SWOT ANALYSIS
FIGURE 53 KANEKA CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 54 KANEKA CORPORATION: SWOT ANALYSIS
FIGURE 55 CSAFE GLOBAL: SWOT ANALYSIS
Assistant Manager - Research High acumen in analyzing complex macro & micro markets with more than 6 years of work experience in the field of market research. by implementing her analytical skills in forecasting and estimation into market research reports, she has expertise in packaging, construction, and equipment domains. she handles a team size of 20-25 resources and ensures smooth running of the projects, associated marketing activities, and client servicing.
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
